Juan C. Rueda

Dr. Juan C. Rueda

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2009 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
ADAlejandra de-la-Torre
Alejandra de-la-Torre
CLChristian Adrián López‐Castillo
Christian Adrián López‐Castillo
JRJuan C. Rueda
Juan C. Rueda
RMRubén Darío Mantilla
Rubén Darío Mantilla
Jorge Enrique Gomez-MarinJorge Enrique Gomez-Marin
Jorge Enrique Gomez-Marin
Juan-Manuel AnayaJuan-Manuel Anaya
Juan-Manuel Anaya

22 September 2007 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
CGClaudi Galarza-Maldonado
Claudi Galarza-Maldonado
DVDiana Valencia
Diana Valencia
GTGabriel J. Tobón
Gabriel J. Tobón
LZLuis Zurita
Luis Zurita
RMRubén D. Mantilla
Rubén D. Mantilla
Juan-Manuel AnayaJuan-Manuel Anaya
Juan-Manuel Anaya

28 April 2013 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
JRJuan C. Rueda
Juan C. Rueda
MCMarie-Francoise Crepy
Marie-Francoise Crepy
RMRubén D. Mantilla
Rubén D. Mantilla

1 October 2018 in Revista Colombiana de Reumatología
Verified
Journal Article
Closed access
JLJohn Londoño
John Londoño
IBIngris Peláez Ballestas
Ingris Peláez Ballestas
FCFrancy Cuervo
Francy Cuervo
IAIgnacio Angarita
Ignacio Angarita
RGRodrigo Giraldo
Rodrigo Giraldo
ASAna María Santos
Ana María Santos

1 April 2009 in JCR: Journal of Clinical Rheumatology
Verified
Journal Article
Closed access
JRJuan C. Rueda
Juan C. Rueda
MDMario Andrés Quintana Duque
Mario Andrés Quintana Duque
RMRubén D. Mantilla
Rubén D. Mantilla
AIAntonio Iglesias-Gamarra
Antonio Iglesias-Gamarra
Osteonecrosis (ON), or avascular necrosis of bone, has been related to decreased blood flow to the bone. Many local and systemic factors have been implicated in the pathogenesis of ON, involving corticosteroid therapy, systemic lupus erythematosus (SLE), hemoglobinopathies, alcohol abuse, Caisson disease, Gaucher disease, and hypercoagulability states. We describe the case of a previously healthy young male with no history of corticosteroid therapy, who developed ON initially on the femoral head, and later on the humeral head with high levels of anticardiolipin antibodies (aCL), beta-2-glycoprotein 1 antibodies and positive lupus anticoagulant. The association between primary antiphospholipid syndrome (PAPS) and ON is controversial and few cases without other risk factors have been described. A review of ON pathogenesis and its relation with thrombotic microangiopathy because of PAPS is presented.

1 January 2019 in Emerging Microbes & Infections
Verified
Journal Article
Open access
JRJuan C. Rueda
Juan C. Rueda
ASAna M. Santos
Ana M. Santos
JAJose-Ignacio Angarita
Jose-Ignacio Angarita
RGRodrigo B. Giraldo
Rodrigo B. Giraldo
ESEugenia-Lucia Saldarriaga
Eugenia-Lucia Saldarriaga
JLJohn Londono
John Londono
In 2014, the chikungunya virus reached Colombia for the first time, resulting in a nationwide epidemic. The objective of this study was to describe the demographics and clinical characteristics of suspected chikungunya cases. Chikungunya infection was confirmed by enzyme-linked immunosorbent assay and 548 patients where included in the study. Of these patients, 295 were positive for antibodies against chikungunya (53.8%), and 27.6% (151/295) were symptomatic for chikungunya infection, with a symptomatic:asymptomatic ratio of 1.04:1. Factors associated with infection included low income and low socio-economic strata (odds ratio [OR]: 1.8; 95% confidence interval [CI]: 1.0–3.2, p = 0.003 and OR: 2.1; CI: 1.3–3.4, p = 0.002, respectively). Confirmed symptomatic cases were associated with symmetric arthritis (OR: 11.7; CI: 6.0–23.0, p < 0.001) of ankles (OR: 8.5; CI: 3.5–20.9, p < 0.001), hands (OR: 8.5; CI: 3.5–20.9, p < 0.001), feet (OR: 6.5; CI: 2.8–15.3, p < 0.001), and wrists (OR: 17.3; CI: 2.3–130.5, p < 0.001). Our study showed that poverty is associated with chikungunya infection. Public health strategies to prevent and control chikungunya should focus on poorer communities that are more vulnerable to infection. The rate of asymptomatic infections among confirmed cases was 48.8%. However, those with symptoms displayed a characteristic rheumatic clinical picture, which could help differentiate chikungunya infection from other endemic viral diseases.